Patents by Inventor Thomas A. Stamey

Thomas A. Stamey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
    Publication number: 20050272052
    Abstract: Many genes are affected in prostate cancers which have not been previously identified. This includes genes that have been up-regulated or down-regulated. Monitoring the expression levels of these genes is useful to identify the existence of prostate cancer. Also, monitoring the expression levels of these genes is useful to predict the effectiveness of treatment, outcome, use of therapeutics, and screening drugs useful for the treatment of prostate cancer.
    Type: Application
    Filed: October 27, 2004
    Publication date: December 8, 2005
    Applicant: Affymetrix, INC.
    Inventors: Mamatha Shekar, Zhaomei Zhang, Mitchell Caldwell, Zuxiong Chen, Zhenbin Fan, John McNeal, Rosalie Nolley, Thomas Stamey, Janet Warrington, John Palma
  • Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
    Publication number: 20040029151
    Abstract: Many genes are affected in prostate cancers which have not been previously identified. This includes genes that have been up-regulated or down-regulated. Monitoring the expression levels of these genes is useful to identify the existence of prostate cancer. Also, monitoring the expression levels of these genes is useful to predict the effectiveness of treatment, outcome, use of therapeutics, and screening drugs useful for the treatment of prostate cancer.
    Type: Application
    Filed: April 9, 2003
    Publication date: February 12, 2004
    Applicant: Affymetrix, INC.
    Inventors: Mamatha Mahadevappa, Zhaomei Zhang, Janet A. Warrington, John F. Palma, Mitchell C. Caldwell, Zuxiong Chen, Zhenbin Fan, John E. McNeal, Rosalie Nolley, Thomas A. Stamey
  • Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis
    Patent number: 5858685
    Abstract: Benign prostatic hyperplasia-prostate specific antigen (BPH-PSA) and methods for its preparation are provided. Also provided are antibodies specific for BPH-PSA, and methods of their use in immunoassays for detecting the presence of BPH-PSA in a sample. The subject immunoassays find use in diagnosing the conditions associated with elevated serum PSA levels, such as prostate cancer and BPH.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: January 12, 1999
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Thomas A. Stamey, Zuxiong Chen, John E. McNeal